The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...

A group representing companies that made copycat versions of Eli Lilly & Co.’s weight-loss drugs sued the US Food and Drug ...

WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...

Meanwhile, cities in New Mexico, Minnesota, Kansas, and Utah are leading the pack for cities who are the most open to trying ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a ...

FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking ...

Surging demand for weight loss drugs Wegovy and Zepbound from Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) has fueled concerns ...